thyTreg

thymic tissue-derived regulatory T cells · Hospital General Universitario Gregorio Marañón

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for thyTreg, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2) [Phase 1, Phase 2]

See pricing